Erik Swain

2 weeks ago | healio.com | Erik Swain |Philippe Généreux

• Edwards Lifesciences’ TAVR platform is the first to be approved in this population. Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe asymptomatic aortic stenosis, the first in this patient population.

2 weeks ago | healio.com | Erik Swain

Two agents targeting ANGPTL3 successful at lowering lipids in phase 2 trials• Solbinsiran and SHR-1918 will be further studied in patients with high lipid levels in phase 3 trials. CHICAGO — Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, according to findings presented at the American College of Cardiology Scientific Session.

3 weeks ago | healio.com | Erik Swain

Sudden cardiac arrest survival rates up for young athletes, but racial disparities exist• Survival from sudden cardiac arrest has improved for young athletes in recent years. • Survival rates varied by race and by setting of event. CHICAGO — Survival from sudden cardiac arrest has improved in young competitive athletes in recent years, but racial disparities in outcomes were observed, researchers reported. Bradley J.

3 weeks ago | healio.com | Erik Swain

• Electronic provider notification led to more aortic valve replacement procedures after a diagnosis of severe aortic stenosis vs. usual care. • There was a trend toward the intervention reducing mortality risk. CHICAGO — Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe aortic stenosis to have aortic valve replacement within 1 year, researchers reported.

3 weeks ago | healio.com | Erik Swain

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the approval of a new drug in late 2024. Congenital adrenal hyperplasia (CAH) is caused by a genetic mutation that hampers production of cortisol and mineralocorticoids in the adrenal gland, and it can lead to a life-threatening adrenal crisis if not treated. Patients with classic CAH have been treated with glucocorticoids since their discovery in the 1950s.